Skip to main content

Logo (Actavis) 638 Pill - yellow capsule-shape, 16mm

Pill with imprint Logo (Actavis) 638 is Yellow, Capsule-shape and has been identified as Lamotrigine Extended-Release 250 mg. It is supplied by Actavis Pharma, Inc.

Lamotrigine is used in the treatment of Bipolar Disorder; Lennox-Gastaut Syndrome; Seizure Prevention; Epilepsy and belongs to the drug class triazine anticonvulsants. Risk cannot be ruled out during pregnancy. Lamotrigine 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Logo (Actavis) 638

Lamotrigine extended-release 250 mg Logo (Actavis) 638

Lamotrigine Extended-Release

Logo (Actavis) 638
250 mg
16.00 mm
Prescription only
Drug Class
Triazine anticonvulsants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Actavis Pharma, Inc.
National Drug Code (NDC)
Inactive Ingredients
hypromelloses, lactose monohydrate, magnesium stearate, methacrylic acid - methyl methacrylate copolymer (1:2), polyethylene glycol 400, silicon dioxide, magnesium silicate, titanium dioxide, triethyl citrate, ferric oxide yellow, ferric oxide red, polydextrose, copovidone, ferrosoferric oxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.